<DOC>
	<DOCNO>NCT01016873</DOCNO>
	<brief_summary>The purpose study confirm safety establish effectiveness two dos IRay System treatment wet AMD .</brief_summary>
	<brief_title>INTREPID - IRay Plus Anti-VEGF Treatment For Patients With Wet AMD</brief_title>
	<detailed_description>The purpose study confirm safety low voltage external beam radiotherapy use IRay System two dose level treatment CNV secondary neovascular AMD determine IRay System effective spar number Lucentis injection first 12 month .</detailed_description>
	<mesh_term>Macular Degeneration</mesh_term>
	<mesh_term>Choroidal Neovascularization</mesh_term>
	<mesh_term>Eye Diseases</mesh_term>
	<mesh_term>Retinal Diseases</mesh_term>
	<mesh_term>Ranibizumab</mesh_term>
	<criteria>Patients must neovascular AMD diagnose within previous 3 year , receive least 3 injection Lucentis® Avastin® within previous year need treatment antiVEGF therapy due increase fluid persistent cyst OCT , leakage FA . Patients must total lesion size &lt; 12 disc area CNV lesion great linear dimension &lt; 6 mm , great 3 mm center fovea furthest point lesion perimeter . The distance center fovea near edge optic disc le 3 mm . Patients must Patient must least 50 year age . Women must postmenopausal ≥1 year surgically sterilize , pregnancy screen must perform prior study reliable form contraception approve investigator must maintain study . Patient must best correct visual acuity 75 25 letter study eye least 20 letter fellow eye . CNV due cause AMD , include ocular histoplasmosis syndrome , angioid streak , multifocal choroiditis , choroidal rupture , pathologic myopia ( spherical equivalent ≥ 8 diopter ) . An axial length ≤20 mm ≥26 mm . Previously diagnose Diabetes Mellitus and/or HbA1c &gt; 6.5 % , retinal finding consistent diabetic retinopathy . Prior concurrent therapy age relate macular degeneration include submacular surgery , subfoveal thermal laser photocoagulation ( without photographic evidence ) , transpupillary thermotherapy ( TTT ) , ocular photodynamic therapy , radiation therapy head neck study eye . Previous posterior vitrectomy , surgery study eye within 6 month YAG capsulotomy within 3 month prior screen visit .</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2014</verification_date>
	<keyword>Oraya</keyword>
	<keyword>Oraya Therapeutics , Inc .</keyword>
	<keyword>low voltage stereotactic radiotherapy</keyword>
	<keyword>radiotherapy</keyword>
	<keyword>IRay</keyword>
	<keyword>Ranibizumab</keyword>
	<keyword>Lucentis</keyword>
	<keyword>AMD</keyword>
	<keyword>Macular Degeneration</keyword>
	<keyword>xray</keyword>
	<keyword>radiation</keyword>
	<keyword>x ray</keyword>
	<keyword>external beam radiation</keyword>
	<keyword>radiosurgery</keyword>
</DOC>